Hims & Hers Health, Inc. (HIMS) EBITDA
The ebitda for Hims & Hers Health, Inc. (HIMS) is $160.12 Million with a year-over-year change of +102.70%. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating performance by removing non-cash charges and capital structure effects.
HIMS EBITDA Chart
Current EBITDA
$160.12M
$160.12 Million
Year-over-Year Change
+102.70%
vs. $78.99M prior year
Historical Data
2
Years of data available
Annual EBITDA History
| Year | EBITDA | YoY Change | % Change |
|---|---|---|---|
| 2025 | $160.12M | +$81.12M | +102.70% |
| 2024 | $78.99M | — | — |
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum